<DOC>
	<DOCNO>NCT00192322</DOCNO>
	<brief_summary>To perform variety assay blood , nasal wash , cell obtain healthy child purpose investigation immune response generate influenza virus vaccine , trivalent , type A B , live , cold-adapted ( liquid CAIV-T ; Wyeth Lederle Vaccines , Marietta , PA ) . â€¢ To assess nasal swab specimen detect vaccine virus shed .</brief_summary>
	<brief_title>Trial Investigate Immune Responses Elicited Liquid Formulation Influenza Virus Vaccine ( CAIV-T ) Healthy Children</brief_title>
	<detailed_description>This phase II , prospective , randomize , partially-blinded , placebo-controlled , outpatient study conduct multiple site throughout US healthy child age 6 month le 36 month . Parents/guardians subject ask read sign inform consent study-related procedure perform . Subjects study site sequentially assign 1 2 separate blood sample group refer `` cellular immunity '' `` antibody secrete cell '' . Subjects within blood sample group randomize 1:1:1:1 receive single intranasal dose CAIV-T 10^7 FFU per dose , CAIV-T 10^5 FFU per dose , placebo commercially-available injectable trivalent influenza vaccine ( TIV ) .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>child least 6 month age le 36 month age time enrollment , good health determine medical history , physical examination clinical judgement ; whose parent/legal guardian provide write informed consent nature study explain ; , along parent guardian , available one month duration trial ( enrollment study completion ) ; whose parent guardians perceived unavailable difficult contact evaluation study visit study period ; serious chronic disease ( e.g. , sign cardiac renal failure severe malnutrition ) , include progressive neurological disease ; Down 's syndrome know cytogenetic disorder ; know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid , cytotoxic agent ( see Section 4.2.2 ) ; immunosuppressed immunocompromised individual living household ; document history hypersensitivity egg egg protein component study vaccine , placebo TIV ; , anytime prior study enrollment , receive influenza vaccine ( commercial investigational ) ; medical condition opinion investigator might interfere interpretation study result . Note : A pregnant household member consider contraindication enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>